androstadienes

Preferred Label : androstadienes;

MeSH definition : Derivatives of the steroid androstane having two double bonds at any site in any of the rings.;

Wikipedia link : https://en.wikipedia.org/wiki/Androstadienes;

Is substance : O;

Details

Origin ID

D000730;

UMLS CUI

C0002852;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- androstadienes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,4-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 11-hydroxy-1,4-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 14,17-dihydroxyandrosta-1,4-dien-3-one [MeSH Supplementary Concept]
- 17 beta-acetoxy-delta-(1,5)-androstadien-3-one [MeSH Supplementary Concept]
- 17 beta-ureido-1,4-androstadien-3-one [MeSH Supplementary Concept]
- 17,17-dimethyl-18-norandrosta-4,13-dien-3-one [MeSH Supplementary Concept]
- 17-(3-pyridyl)androsta-5,16-dien-3-one [MeSH Supplementary Concept]
- 17-(5'-isoxazolyl)androsta-4,16-dien-3-one [MeSH Supplementary Concept]
- 17-(N,N,-diisopropylcarbamoyl)androst-3,5-diene-3-carboxylic acid [MeSH Supplementary Concept]
- 17-chloro-16-formylandrosta-5,16-dien-3beta-yl acetate [MeSH Supplementary Concept]
- 17-chloroandrosta-5,16-dien-3beta-yl acetate [MeSH Supplementary Concept]
- 17-cyano-5,16-androstadien-3 beta-ol-3-acetate [MeSH Supplementary Concept]
- 17-dihydroexemestane [MeSH Supplementary Concept]
- 17-hydroxy-16-iodowortmannin [MeSH Supplementary Concept]
- 17-hydroxyexemestane [MeSH Supplementary Concept]
- 17-hydroxyexemestane-17-O-glucuronide [MeSH Supplementary Concept]
- 17-hydroxywortmannin [MeSH Supplementary Concept]
- 17beta-hydroxy-16alpha-iodo-wortmannin [MeSH Supplementary Concept]
- 1alpha,3-dipyrrolidino-androsta-3,5-diene-17-one [MeSH Supplementary Concept]
- 3'-azido-3'-deoxy-5'-O-((16-cyano-11-hydroxy-3-oxo-17-androsta-1,4-dienyl)carbonyl)thymidine [MeSH Supplementary Concept]
- 3,7-dihydroxy-5,9,17-trioxo-4(5),9(10)-disecoandrosta-1(10)2-dien-4-oic acid [MeSH Supplementary Concept]
- 3-acetoxyandrost-1,5-dien-17-ethylene ketal [MeSH Supplementary Concept]
- 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 3-hydroxy-17-(imidazol-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 3-hydroxy-5,15-androstadien-17-one [MeSH Supplementary Concept]
- 3-hydroxyandrosta-5,7-dien-17-one [MeSH Supplementary Concept]
- 3-hydroxyandrosta-5,7-diene-17-carboxylic acid [MeSH Supplementary Concept]
- 3beta-(1H-imidazole-1-yl-17-(1H-benzimidazole-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 4,16-androstadien-3-one [MeSH Supplementary Concept]
- 4,6-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 4,9-androstadien-3,17-dione [MeSH Supplementary Concept]
- 5-(acetyloxy)-1-((N-(5-carboxypentyl)-N-methylamino)methylene)-4,4a,5,6,6a,8,9,9a-octahydro-11-hydroxy-4-(methoxymethyl)-4a,6a-dimethylcyclopenta(5,6)naphtho(1,2-c)pyran-2,7,10-(1H)-trione [MeSH Supplementary Concept]
- 5-(acetyloxy)-1-((N-(5-carboxypentyl)amino)methylene)-4,4a,5,6,6a,8,9,9a-octahydro-11-hydroxy-4-(methoxymethyl)-4a,6a-dimethylcyclopenta(5,6)naphtho(1,2-c)pyran-2,7,10-(1H)-trione [MeSH Supplementary Concept]
- 6-methyl-B-norandrostenedione [MeSH Supplementary Concept]
- 7,12-dihydroxyandrosta-1,4-diene-3,17-dione [MeSH Supplementary Concept]
- 7-((4'-aminophenyl)thio)-1,4-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 9-fluoro-16alpha-methyl-11,17-dihydroxy-3-oxo-1,4-androstadiene-17beta-carboxylic acid [MeSH Supplementary Concept]
- BR 917 [MeSH Supplementary Concept]
- FCE 27993 [MeSH Supplementary Concept]
- FPL 66365XX [MeSH Supplementary Concept]
- FPL 66366XX [MeSH Supplementary Concept]
- FPL 67336XX [MeSH Supplementary Concept]
- KT 7692 [MeSH Supplementary Concept]
- MP29-02 [MeSH Supplementary Concept]
- N-(1',1'-dimethylethyl)-3-fluoroandrost-3,5-dien-17-carboxamide [MeSH Supplementary Concept]
- PJ 91 compound [MeSH Supplementary Concept]
- SQ 28300 [MeSH Supplementary Concept]
- TZA 2237 [MeSH Supplementary Concept]
- VNPP433-3beta [MeSH Supplementary Concept]
- VNPT55 [MeSH Supplementary Concept]
- andrastin A [MeSH Supplementary Concept]
- andrastin B [MeSH Supplementary Concept]
- andrastin C [MeSH Supplementary Concept]
- androsta-3,5-diene-7,17-dione [MeSH Supplementary Concept]
- androsta-4,16-diene-3,6-dione [MeSH Supplementary Concept]
- citreohybridonol [MeSH Supplementary Concept]
- delta1-cortienic acid [MeSH Supplementary Concept]
- epristeride [MeSH Supplementary Concept]
- exemestane [MeSH Supplementary Concept]
- fluticasone furoate [MeSH Supplementary Concept]
- fluticasone furoate-vilanterol trifenatate [MeSH Supplementary Concept]
- fluticasone propionate-17-carboxylic acid [MeSH Supplementary Concept]
- fluticasone-formoterol [MeSH Supplementary Concept]
- pegylated 17-hydroxywortmannin [MeSH Supplementary Concept]
- quinbolone [MeSH Supplementary Concept]
- roxibolone [MeSH Supplementary Concept]
- spirorenone [MeSH Supplementary Concept]
- timobesone acetate [MeSH Supplementary Concept]
- tipredane [MeSH Supplementary Concept]
- wortmannine E [MeSH Supplementary Concept]
- wortmannolone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients